Malignant Brain Tumor
📧 Sign up to get email alerts when something new happens for Malignant Brain Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
A Mayo Clinic-sponsored clinical trial is investigating the brain-gut axis and gut microbiome in patients with malignant brain tumors and is…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients [Phase 1]
A Phase 1 safety study evaluating repeated opening of the blood-brain barrier using the SonoCloud device to treat pediatric malignant brain …
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
A clinical trial update from Xuanwu Hospital Beijing describing the recruitment of a multi-tracer PET/MR imaging study for neurological diso…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Psychological Intervention For Brain Tumor Caregivers [NA]
A Massachusetts General Hospital trial evaluating a psychological intervention for caregivers of brain tumor patients has completed. The stu…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors [Phase 1]
A Phase 1 trial of ABM-1310 for BRAF V600-mutant relapsed and drug-resistant primary malignant brain tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors [Phase 1, Phase 2]
Clinical trial updates the evaluation of an IDO inhibitor in combination with temozolomide for adult malignant brain tumors, including gliob…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children [Phase 2]
Phase 2 pilot study of cabozantinib for recurrent or progressive central nervous system tumors in children has been terminated; results were…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects [Phase 2]
Phase 2 trial evaluating combination of an oncolytic adenovirus with pembrolizumab for brain cancers has completed.
-
CLINICAL_TRIALS safety_alert · 2017-05-30Clinical Trial Update: Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Clinical trial update indicating that temozolomide may cause changes in semen or sperm in patients with primary malignant brain tumors.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer [NA]
The clinical trial investigating a computer-based intervention for distance caregivers of parents with advanced cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE) [Phase 2]
Phase 2 imaging study of XERECEPT for peritumoral brain edema and brain tumors has been terminated.